Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

Circulation

Volumn 95, Issue 1, 1997, Pages 76-82

  Tamai, Osamu ^a   Matsuoka, Hidehiro ^a   Itabe, Hiroyuki ^b   Wada, Yoshifumi ^a   Kohno, Keisuke ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

acetylcholine; arteriosclerosis; blood flow; endothelium derived factors; lipoproteins

Indexed keywords

ACETYLCHOLINE; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE;

APHERESIS; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; VASODILATATION;

EID: 0031014389     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.1.76     Document Type: Article

References (13)

1. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge Gil, Alexander RW, Gantz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986; 315:1046-1051.
2. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low-density lipoprotein that increases its atherogenicity. N Engl J Med. 1989;320:915-924.
3. Lüscher TF, Tanner FC. Endothelial regulation of vascular tone and growth. Am J Hypertens. 1993;6:283S-293S.
4. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990; 86:228-234.
5. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491-497.
6. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans: progressive cndothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
7. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 1992;340:1430-1432.
8. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation in hypercholesterolemic patients. Circulation. 1993;88:2541-2547.
9. Gilligan DM, Guetta V, Panza JA, Garcia CE, Quyyumi AA, Canon RO III. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation. 1994;90:35-41.
10. Leung WH, Lau C-P, Wong C-K. Beneficial effect of cholesterollowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet. 1993;341:1496-1500.
11. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation. 1994;89:2519-2524.
12. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995;332: 488-493.
13. Gotto AM Jr. Lipid lowering, regression, and coronary events: a review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention, seventh council meeting. Circulation. 1995;92:646-656.